|
rdfs:label
|
"Safinamid"@de
"Safinamid"@sh
"Safinamid"@sr
"Safinamida"@id
"Safinamide"@it
"Safinamidum"@la
"Safinamidă"@ro
"safinamid"@sl
"safinamida"@ca
"safinamida"@es
"safinamida"@pt
"safinamide"@en
"safinamide"@fr
"Сафинамид"@ru
"ספינאמיד"@he
"سافيناميد"@ar
"سافيناميد"@arz
"ସଫିନାମାଇଡ"@or
"サフィナミド"@ja
"沙芬醯胺"@zh
|
|
skos:altLabel
|
"EMD 1195686"@en
"EMD-1195686"@en
"Safinamide"@en
"Xadago"@en
"Xadago®"@en
"méthanesulfonate de safinamide"@fr
|
|
schema:description
|
"cheemesch Verbindung"@lb
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuestu químicu"@ast
"compus chimic"@ro
"drug indicated for the treatment of Parkinson's disease"@en
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kemična spojina"@sl
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"medicamento indicado para el tratamiento de la enfermedad de Parkinson"@es
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
|
|
schema:dateModified
|
"2026-11-04T13:22:58+00:00"^^xsd:dateTime
|
|
schema:version
|
2564703907
|
|
wikibase:identifiers
|
27
|
|
wikibase:sitelinks
|
15
|
|
wikibase:statements
|
44
|
|
p:P10245
|
wd:statement/Q2211523-a4c51300-4fe7-18c9-57b6-4a026cd2d356
|
|
p:P11089
|
wd:statement/Q2211523-079C91AE-DB7B-413B-A95A-EDC09FB3770E
|
|
p:P11143
|
wd:statement/Q2211523-C085D1E3-3048-408E-A0C8-4D7777D0FCE3
|
|
p:P11198
|
wd:statement/Q2211523-CB94BF09-25C1-4B18-B59F-EF0ACF1A2152
|
|
p:P11199
|
wd:statement/Q2211523-DEAC1AFB-8EF9-4451-9289-88DC6B8D27F5
|
|
p:P117
|
wd:statement/Q2211523-DD02B734-0F1F-4A64-8663-AE0204F8CB98
|
|
p:P129
|
wd:statement/Q2211523-03A97836-A0F2-404F-9ED6-0B8945F12DF0
|
|
wd:statement/Q2211523-1C2A2F96-F88C-406B-AFE9-82D24FE3F20A
|
|
p:P1748
|
wd:statement/Q2211523-E16EAED4-45CE-4D4B-9398-FD68248AFF24
|
|
p:P2017
|
wd:statement/Q2211523-CC38B4F3-E042-43CE-BFB4-FA26646190E0
|
|
p:P2067
|
wd:statement/Q2211523-3E73F27C-1114-481E-8768-12262F3863E9
|
|
p:P2115
|
wd:statement/Q2211523-223377D5-6ABF-4FFD-B3CC-7C135C14B8FF
|
|
p:P2175
|
wd:statement/Q2211523-0E408371-C485-48CE-AAE6-DD4459D3B220
|
|
p:P231
|
wd:statement/Q2211523-652EC259-DDB5-4757-9665-90FB1662402D
|
|
p:P232
|
wd:statement/Q2211523-7285BD88-878D-4EA3-973F-C683BB8AE222
|
|
p:P233
|
wd:statement/Q2211523-C2710107-3428-463F-8F40-31955A57270F
|
|
p:P234
|
wd:statement/Q2211523-1D25DEC8-F7B5-4C13-913D-007037604627
|
|
p:P235
|
wd:statement/Q2211523-AAD2663B-A274-4DCF-B2E5-6680B6762708
|
|
p:P2566
|
wd:statement/Q2211523-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q2211523-D3ACCD90-1A99-4D3A-B403-1EFF81AD7465
|
|
p:P274
|
wd:statement/Q2211523-D87BE23C-FA42-47DA-9FFB-5D47C13A7832
|
|
p:P279
|
wd:statement/Q2211523-1E8A5E1F-7293-48B0-A945-9A9428C19EB3
|
|
p:P2877
|
wd:statement/Q2211523-0A75F3CD-216D-4480-98DC-88ABF511FF75
|
|
p:P31
|
wd:statement/Q2211523-5458AE47-4E9F-49C0-BF3F-9F510BA4EF03
|
|
p:P3117
|
wd:statement/Q2211523-4253CF3B-3709-4D05-92BC-9AAF4B3A2543
|
|
p:P3345
|
wd:statement/Q2211523-4538DA56-7DE6-4634-999A-FF31BF72E49C
|
|
p:P3364
|
wd:statement/Q2211523-5AB276AA-BAE7-4A5A-9BE5-337CF3466F7E
|
|
p:P366
|
wd:statement/Q2211523-BB50F281-2A3B-413E-9CD1-3F6855240AF4
|
|
p:P373
|
wd:statement/Q2211523-7C1158BD-AE12-4FA0-B9D9-AD7610586837
|
|
p:P3780
|
wd:statement/Q2211523-04A29B56-EB91-41B9-9239-3BA9613E4437
|
|
p:P4250
|
wd:statement/Q2211523-47A16CD6-0C4D-43E7-A406-8603185C5B38
|
|
p:P592
|
wd:statement/Q2211523-B7B817B0-53BA-4A8B-AE3E-B8A974697DD7
|
|
p:P595
|
wd:statement/Q2211523-D6C3C7B8-0165-44E3-97DA-F1D5AB901B49
|
|
p:P6366
|
wd:statement/Q2211523-0779FF6C-CCFE-4815-9C47-2DBBF0C8F689
|
|
p:P646
|
wd:statement/Q2211523-9809F8FE-3071-4312-8EDE-C5FE000915CD
|
|
p:P652
|
wd:statement/Q2211523-B56314C2-71EF-4CBD-B018-553B10BE66CD
|
|
p:P661
|
wd:statement/Q2211523-F739703C-18D7-4360-9E71-16E884CB6282
|
|
p:P662
|
wd:statement/Q2211523-94D3A736-B70C-4563-89D8-EA0260362BD3
|
|
p:P665
|
wd:statement/Q2211523-0458897C-2141-489A-A0F8-A63EF6F332D0
|
|
p:P683
|
wd:statement/Q2211523-8B447C17-A9C1-4491-BF6E-C19BDE035886
|
|
p:P715
|
wd:statement/Q2211523-EF9D98BD-89FF-4D8C-BF35-E565599E123A
|
|
p:P7830
|
wd:statement/Q2211523-BD46D050-EF9B-4090-BDA3-EDF78B1D626E
|
|
p:P8026
|
wd:statement/Q2211523-28898241-2A05-4DAB-B696-C9286DA3D46B
|
|
p:P8494
|
wd:statement/Q2211523-EBE230D6-7F8A-4E59-A5E6-175F1ED1FF8B
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000193464>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL396778>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2776493724>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/116349>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131682>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D10158>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_134718>
|
|
wdt:P10245
|
"a617025"
|
|
wdt:P11089
|
"138162"
|
|
wdt:P11143
|
"Safinamide"
|
|
wdt:P11198
|
"4921"
|
|
wdt:P11199
|
"PD012205"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Safinamide.svg>
|
|
wdt:P129
|
Monoamine oxidase B
|
|
wdt:P1748
|
"C76771"
|
|
wdt:P2017
|
"C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O"
|
|
wdt:P2067
|
302.143056^^xsd:decimal
|
|
wdt:P2115
|
"N0000193464"
|
|
wdt:P2175
|
Parkinson's disease
|
|
wdt:P231
|
"133865-89-1"
|
|
wdt:P232
|
"603-772-2"
|
|
wdt:P233
|
"CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F"
|
|
wdt:P234
|
"InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1"
|
|
wdt:P235
|
"NEMGRZFTLSKBAP-LBPRGKRZSA-N"
|
|
wdt:P2566
|
"100.120.167"
|
|
wdt:P267
|
"N04BD03"
|
|
wdt:P274
|
"C₁₇H₁₉FN₂O₂"
|
|
wdt:P279
|
Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-
|
|
wdt:P2877
|
"69350"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID601010282"
|
|
wdt:P3345
|
"1922448"
|
|
wdt:P3364
|
(2R)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Safinamide"
|
|
wdt:P3780
|
Xadago
|
|
wdt:P4250
|
75.0^^xsd:decimal
|
|
wdt:P592
|
"CHEMBL396778"
|
|
wdt:P595
|
"8291"
|
|
wdt:P6366
|
"2776493724"
|
|
wdt:P646
|
"/m/04jmqqw"
|
|
wdt:P652
|
"90ENL74SIG"
|
|
wdt:P661
|
"116349"
|
|
wdt:P662
|
"131682"
|
|
wdt:P665
|
"D10158"
|
|
wdt:P683
|
"134718"
|
|
wdt:P715
|
"DB06654"
|
|
wdt:P7830
|
"Safinamide"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category E
|
|
wdt:P8494
|
"DTXCID701436700"
|